1 of 20

Assessment of Medication & Polypharmacy in Older Adults���Pavithra Nanayakkara�University of Ruhuna

2 of 20

Objectives

  • Explain the significance of Polypharmacy in Older Adults
  • Identify common tools used to measure comorbidity in geriatric patients.
  • Explain the strategies to assess the Medication & Polypharmacy in Older Adults
  • Describe strategies to reduce polypharmacy and promote safe medication use in geriatrics

3 of 20

Introduction

  • As people age, they are more likely to develop multiple chronic conditions, leading to the use of multiple medications—a phenomenon known as polypharmacy.
  • Assessing medication use in older adults is essential for ensuring safety, preventing adverse events, and promoting optimal health outcomes.

4 of 20

Definitions

Polypharmacy

  • Traditionally defined as the use of five or more medications simultaneously.
  • May include prescription drugs, over-the-counter (OTC) medications, vitamins, and herbal supplements.

Inappropriate Polypharmacy

  • The use of more medications than are clinically necessary or the use of potentially inappropriate medications (PIMs) that pose a greater risk than benefit in older adults.

5 of 20

Significance of Polypharmacy in Older Adults

A. Increased Risk of Adverse Drug Events (ADEs)

  • Older adults have reduced renal and hepatic function, altering drug metabolism and clearance.
  • Higher risk of falls, confusion, constipation, bleeding, and hospitalization.

B. Drug-Drug and Drug-Disease Interactions

  • Some medications may exacerbate existing diseases (e.g., NSAIDs worsening hypertension or kidney disease).

C. Non-Adherence

  • Complex medication regimens may lead to intentional or unintentional non-adherence.

D. Functional Decline

  • Sedating medications or those affecting cognition may impair mobility, increase fall risk, and reduce independence.

6 of 20

  • Comprehensive Medication Review (CMR)
  • A structured review of all medications a patient is taking.
  • Conducted by physicians, pharmacists, or nurses.
  • Includes evaluation of indication, dosage, efficacy, side effects, duplication, and interactions

Assessment Strategies

7 of 20

  • History Taking

Collect detailed information on:

  • Prescription drugs
  • OTC medications
  • Herbal supplements
  • Administration times and methods
  • Patient understanding and adherence

8 of 20

  • Beers Criteria

Assessment Tools and Criteria

Lists potentially inappropriate medications (PIMs) for older adults.

Updated periodically.

Organized into:

  • Medications to avoid in all older adults
  • Medications to avoid in specific diseases
  • Drug-drug interactions
  • Dose adjustments based on kidney function

9 of 20

  • STOPP/START Criteria
  • STOPP: Screening Tool of Older Persons' Prescriptions – identifies potentially inappropriate medications.
  • START: Screening Tool to Alert to Right Treatment – identifies potentially omitted beneficial treatments.

10 of 20

  • Medication Appropriateness Index (MAI)

Scores each medication based on:

    • Indication, effectiveness, dosage, directions, drug-drug interaction, drug-disease interaction, duplication, and cost.

https://www.hqsc.govt.nz/assets/Our-work/System-safety/Reducing-harm/Medicines/Publications-resources/Use-of-the-Medication-Appropriateness-Index.pdf

11 of 20

  • ARMOR Tool
  • Assess, Review, Minimize, Optimize, Reassess
  • A clinical framework to evaluate medications in frail older adults, often in nursing homes or hospitals

12 of 20

Steps of ARMOR Intervention

  • Assess
  • Review for possible
  • Minimize nonessential medication
  • Optimize
  • Reassess

13 of 20

Special Considerations in Assessment

  • High-Risk Drug Classes
  • Benzodiazepines (e.g., diazepam)
  • Anticholinergics (e.g., diphenhydramine)
  • NSAIDs
  • Antipsychotics
  • Hypoglycemics (e.g., sulfonylureas)
  • Cardiovascular medications (e.g., digoxin)

14 of 20

  • Renal and Hepatic Function
  • Many medications require dose adjustments based on estimated glomerular filtration rate (eGFR).
  • Cognitive and Sensory Impairments
  • Visual, hearing, or memory impairments may affect ability to manage medications independently.
  • Polypharmacy in Palliative and End-of-Life Care
  • Focus shifts to symptom control, and deprescribing becomes essential.

15 of 20

Strategies for Optimizing Medication Use

  • Deprescribing
  • A systematic process of tapering or stopping drugs that may no longer be beneficial or may be harmful.
  • Includes shared decision-making with patient and caregivers.
  • Use of Medication Aids
  • Pill organizers
  • Medication administration charts
  • Electronic reminders

16 of 20

  • Involving Pharmacists and Interdisciplinary Teams
  • Pharmacist-led reviews improve outcomes by identifying medication-related problems and optimizing regimens.
  • Patient and Caregiver Education
  • Improve awareness of medication purpose, side effects, and correct administration.

17 of 20

Challenges in Medication Assessment

  • Polypharmacy normalization: Some patients and providers view multiple medications as unavoidable.
  • Time constraints: Limited consultation time in clinics and hospitals.
  • Communication gaps: Between specialists and primary care providers.
  • Lack of access to complete medication records, especially in transitions of care.

18 of 20

Role of Nurses in Medication Assessment

  • Monitoring for adverse effects and adherence.
  • Educating patients and caregivers.
  • Supporting medication reconciliation during transitions of care.
  • Collaborating with pharmacists and physicians for timely interventions.

19 of 20

References

  • Elbeddini, A. (2023). Deprescribing and polypharmacy in an aging population. Springer Nature.�
  • Zagaria, M. A. (Ed.). (2018). Polypharmacy: An issue of Clinics in Geriatric Medicine. Elsevier.�
  • Jandu, J. S. (2024). Strategies to reduce polypharmacy in older adults. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK574550/

20 of 20

Thank you